Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Cancer of Endometrium

indazoles has been researched along with Cancer of Endometrium in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (50.00)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Azaïs, H; Bats, AS; Bentivegna, E; Blons, H; Delanoy, N; Durdux, C; Koual, M; Laurent-Puig, P; Le Frère-Belda, MA; Le Gac, M; Nguyen-Xuan, HT; Perkins, G1
Hattori, Y; Ito, M; Iwata, H; Maeda, O; Mitsuishi, T; Murakami, F; Nagasaka, T; Ogino, H; Uematsu, T1
Gao, H; Wang, Q; Xu, Y; Zhang, F1
Bitler, BG; Bradford, AP; Corr, BR; Moroney, MR; Qamar, L; Wolsky, R; Woodruff, E1
Downward, J; Lambros, MB; Reis-Filho, JS; Warne, PH; Weigelt, B1
de Waal, YR; Leenders, W; Ottevanger, PB; Tops, B; van der Steen, MJ; Westermann, A1
Dong, P; Hanley, SJ; Hirata, N; Ihira, K; Konno, Y; Kudo, M; Noguchi, M; Sakuragi, N; Suizu, F; Watari, H; Xiong, Y; Yamada, T1
Bonazzi, VF; Cummings, MC; Geng, X; Ju, RJ; Mahon, CE; Packer, LM; Pollock, PM; Stephenson, SA1

Reviews

1 review(s) available for indazoles and Cancer of Endometrium

ArticleYear
[Place of PARP inhibitors in the treatment of endometrial and cervical cancers].
    Bulletin du cancer, 2022, Volume: 109, Issue:1

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Clinical Trials as Topic; DNA Damage; DNA Repair-Deficiency Disorders; Endometrial Neoplasms; Female; Humans; Indazoles; Indoles; Ovarian Neoplasms; Papillomavirus Infections; Phthalazines; Piperazines; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Uterine Cervical Neoplasms

2022

Other Studies

7 other study(ies) available for indazoles and Cancer of Endometrium

ArticleYear
Long-term multidisciplinary treatment including proton therapy for a recurrent low-grade endometrial stromal sarcoma and pathologically prominent epithelial differentiation: an autopsy case report.
    BMC women's health, 2020, 07-25, Volume: 20, Issue:1

    Topics: Adult; Autopsy; Drainage; Endometrial Neoplasms; Fatal Outcome; Female; Humans; Indazoles; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proton Therapy; Pyrimidines; Sarcoma, Endometrial Stromal; Sepsis; Sulfonamides; Young Adult

2020
Successful treatment of a patient with brain metastases from endometrial cancer using Niraparib: a case report.
    Annals of palliative medicine, 2021, Volume: 10, Issue:1

    Topics: Brain Neoplasms; China; Endometrial Neoplasms; Female; Humans; Indazoles; Middle Aged; Piperidines

2021
Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
    Molecular carcinogenesis, 2021, Volume: 60, Issue:8

    Topics: beta Catenin; Cell Line, Tumor; Cell Survival; Disease Management; Disease Susceptibility; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Indazoles; Molecular Targeted Therapy; Mutation; Pyridines; Recurrence; Wnt Proteins; Wnt Signaling Pathway

2021
PI3K pathway dependencies in endometrioid endometrial cancer cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jul-01, Volume: 19, Issue:13

    Topics: Apoptosis; Cell Line, Tumor; Class Ia Phosphatidylinositol 3-Kinase; Endometrial Neoplasms; Female; Gene Silencing; Humans; Indazoles; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; ras Proteins; Signal Transduction; Sulfonamides

2013
An impressive response to pazopanib in a patient with metastatic endometrial carcinoma.
    The Netherlands journal of medicine, 2016, Volume: 74, Issue:9

    Topics: Abdominal Wall; Angiogenesis Inhibitors; Carcinoma, Endometrioid; Chemoradiotherapy, Adjuvant; Endometrial Neoplasms; Female; Humans; Hysterectomy; Indazoles; Intestinal Fistula; Middle Aged; Neoplasm Metastasis; Ovariectomy; Pyrimidines; Remission Induction; Salpingectomy; Soft Tissue Neoplasms; Sulfonamides

2016
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
    Oncotarget, 2017, Feb-21, Volume: 8, Issue:8

    Topics: Animals; Cell Line, Tumor; Disease Progression; Endometrial Neoplasms; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Female; Humans; Indazoles; Mice; Mice, Inbred BALB C; MicroRNAs; Nuclear Proteins; Pyridones; Transfection; Twist-Related Protein 1; Xenograft Model Antitumor Assays

2017
PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:4

    Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Mice; Morpholines; Mutation; Phenylurea Compounds; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Sulfonamides; Thiazoles; Xenograft Model Antitumor Assays

2017